AuraCyt™ is revolutionising biotech, from development to manufacturing. It accelerates biological drug discovery and development, and streamlines manufacturing, with real-time monitoring and better prospects for automation.
By harnessing the power of dielectric spectroscopy and microelectronics, AuraCyt™ characterises cells without the need for labels. This improves the pace and accuracy of single cell analysis.
AuraCyt™ addresses the analytical challenges of cell and gene therapy developers, with fast and sensitive detection of single-cell attributes. The platform generates predictive analytics for consistent decision-making without operator bias.
AuraCyt™ is the only scalable technology that can measure cellular physiology, based on real-time intrinsic single-cell properties.
By detecting internal and external features to create a unique ‘fingerprint’ for every single cell, AuraCyt™ provides information on cell properties that other technologies simply can’t. Whether used alone or alongside flow cytometry, AuraCyt™ ushers in a transformative paradigm shift to improve and optimise R&D.
AuraCyt™ is the only scalable technology that can measure cellular physiology, based on real-time intrinsic single-cell properties. The fact that it can do this in a label-free manner means that a multitude of features can be assessed, without having to pre-define specific parameters. With improved pace and accuracy of single cell analysis, AuraCyt™ removes the glass ceiling of cell analytics, enabling us to “see the unseen”.
For more information about AuraCyt™’s applications, click here.
To find out more about our revolutionary biotechnology, please click below and complete our form.